NAMI Advocacy Actions

NAMI works with policymakers to advance priority issues and ensure that the voice of people affected by mental illness is considered in policymaking. Read NAMI’s recent letters to federal leaders, submitted comments and testimony and other resources.

Filter By:
Letter to Congressional Leadership on Health Coverage
02/11/2022
Letter to Speaker Pelosi and Leader Schumer, urging Congress to permanently expand ACA programs including the enhanced advance premium tax credits (APTCs) and close the Medicaid coverage gap in the Fiscal Year 2022 budget reconciliation process.
Statement for the Record on Child and Adolescent Mental Health
02/08/2022
Statement for the Record to Senate Finance Committee on the hearing, “Protecting Youth Mental Health: Part I - An Advisory and Call to Action.”
Regulatory Comment to HHS Secretary on Medicaid & Criminal Justice
02/03/2022
Regulatory comments to HHS Secretary Becerra, commenting on the Massachusetts Medicaid proposal that would extend postpartum Medicaid coverage; expanding Medicaid coverage and services for justice-involved individuals; and continue and expand support for the behavioral health workforce.
Regulatory Comments to HHS Secretary on Medicaid
02/02/2022
Regulatory comments to HHS Secretary Becerra, expressing support for Massachusetts' 1115 Demonstration Extension Request for the MassHealth Program.
Letter to DOL Secretary on Parity
02/02/2022
Letter to DOL Secretary Walsh, expressing support for, and request a meeting on, making mental health parity a priority.
Letter to Congressional Committee Leadership on Mental Health Funding
02/01/2022
Letter to HELP Committee leadership Chairwoman Murray and Ranking Member Burr, urging the committee to bring forward the mental health bills awaiting consideration.
Letter to the Biden Administration on Health Coverage
01/31/2022
Letter to HHS Secretary Becerra, IRS Commissioner Rettig, CMS Administrator Brooks-LaSure, and DOL Acting Assistant Secretary Khawar asking that the agencies issue new regulations as soon as possible limiting the sale and availability of short-term, limited-duration (“STLD”) health insurance.
Regulatory Comments to CMS Administrator on Health Coverage
01/27/2022
Regulatory comments to CMS Administrator Brooks-LaSure and CCIIO Director Montz, on the Patient Protection and Affordable Care Act; HHS Notice of Benefit and Payment Parameters for 2023 proposed rule.
Regulatory Comments to HHS Secretary on Health Coverage
01/27/2022
Regulatory comments to HHS Secretary Becerra, on the Patient Protection and Affordable Care Act; HHS Notice of Benefit and Payment Parameters for 2023 proposed rule.
Regulatory Comment to CMS Administrator on Health Coverage
01/27/2022
Regulatory comments to CMS Administrator Brooks-LaSure on the Centers for Medicare & Medicaid Services’ proposed rule entitled “HHS Notice of Benefit and Payment Parameters for 2023.”
Displaying results 101-110 (of 245)
 <  7 - 8 - 9 - 10 - 11 - 12 - 13 - 14 - 15 - 16  >